Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4Y86

Crystal structure of PDE9 in complex with racemic inhibitor C33

Summary for 4Y86
Entry DOI10.2210/pdb4y86/pdb
Related4Y87
DescriptorHigh affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, 6-{[(1S)-1-(4-chlorophenyl)ethyl]amino}-1-cyclopentyl-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, ZINC ION, ... (6 entities in total)
Functional Keywordsphosphodiesterase 9a, inhibitor selectivity pocket, pharmacokinetics, enantiomeric differentiation, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight124473.26
Authors
Huang, M. (deposition date: 2015-02-16, release date: 2015-09-16, Last modification date: 2024-02-28)
Primary citationHuang, M.,Shao, Y.,Hou, J.,Cui, W.,Liang, B.,Huang, Y.,Li, Z.,Wu, Y.,Zhu, X.,Liu, P.,Wan, Y.,Ke, H.,Luo, H.B.
Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor.
Mol.Pharmacol., 88:836-845, 2015
Cited by
PubMed: 26316540
DOI: 10.1124/mol.115.099747
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.01 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon